You are here

  • Home
  • Archive
  • Volume 4, Issue 1
  • Acute rhabdomyolysis with severe polymyositis following ipilimumab-nivolumab treatment in a cancer patient with elevated anti-striated muscle antibody

Article metrics

Article menu

Download PDFPDF

Case Report
Acute rhabdomyolysis with severe polymyositis following ipilimumab-nivolumab treatment in a cancer patient with elevated anti-striated muscle antibody

 

Online download statistics by month:

Online download statistics by month: December 2019 to August 2024

AbstractFullPdf
Dec 2019220
Jan 2020550
Feb 202011115
Mar 202018181
Apr 202013131
May 202019191
Jun 202016164
Jul 202029292
Aug 202023211
Sep 2020232314
Oct 202032323
Nov 202021205
Dec 202020204
Jan 202123234
Feb 202115156
Mar 202118181
Apr 202131311
May 202130281
Jun 202116161
Jul 202116161
Aug 202114145
Sep 202141414
Oct 202135353
Nov 202130295
Dec 202147475
Jan 202226295
Feb 202216162
Mar 202243435
Apr 202234354
May 202248485
Jun 202259604
Jul 202253546
Aug 202271725
Sep 202254588
Oct 202252523
Nov 2022404214
Dec 202227270
Jan 202335351
Feb 202360601
Mar 202344458
Apr 202326274
May 202338382
Jun 202343432
Jul 2023404013
Aug 202330327
Sep 2023313110
Oct 202355556
Nov 202330303
Dec 202376765
Jan 202430315
Feb 202452526
Mar 202453548
Apr 202436362
May 202456584
Jun 202455558
Jul 202461618
Aug 202449496
Total19711986248